Published in
Springer, Gastric Cancer, 2(22), p. 355-362, 2018
DOI: 10.1007/s10120-018-0861-7
Links
Tools
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer
Journal article published in 2018 by
Sebastian Mondaca,
Matthew Margolis,
Francisco Sanchez-Vega 
,
Philip Jonsson,
Jamie C. Riches,
Geoffrey Y. Ku,
Jaclyn F. Hechtman,
Yaelle Tuvy,
Michael F. Berger,
Manish A. Shah,
David P. Kelsen,
David H. Ilson,
Kenneth Yu,
Zoe Goldberg,
Andrew S. Epstein
and other authors.
,
Philip Jonsson,
Jamie C. Riches,
Geoffrey Y. Ku,
Jaclyn F. Hechtman,
Yaelle Tuvy,
Michael F. Berger,
Manish A. Shah,
David P. Kelsen,
David H. Ilson,
Kenneth Yu,
Zoe Goldberg,
Andrew S. Epstein
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 